PureTech's Vor files for proposed Nasdaq IPO

PureTech Health announced on Monday that its founded entity Vor Biopharma has filed a public registration statement with the US Securities and Exchange Commission (SEC) for a proposed initial public offering of shares.

The FTSE 250 company said the number of shares to be offered and the price range for the offering had not yet been determined.

“The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering,” the PureTech board said in its statement.

It said Vor was intending to list its common stock under the symbol ‘VOR’ on the Nasdaq Global Market.

At 0810 GMT, shares in PureTech Health were down 0.24% at 380.6p.